Thus, HD-MyZ xenograft showed a combined inhibition of ERK1/2 and Akt phosphorylation on both tumor and endothelial cells, whereas the remaining lymphoma xenografts showed a selective inhibition of either ERK1/2 or Akt pathways on both tumor and vascular cells (Figure 7). The gene discussed is AKT1; the disease is lymphoma.